HEART评分与路径的终端用户指南
该综述讨论HEART评分与路径的组成部分及当前和未来应用考量。急诊胸痛常见,急性冠脉综合征(ACS)虽受关注但仅占少数,急诊医师漏诊心肌梗死(MI)或ACS的比率低于1%。HEART评分与路径基于病史、心电图、肌钙蛋白、年龄和风险因素将患者准确分层,对主要不良心脏事件(MACE)显示高敏感性,可补充临床决策。
要点
- 急诊医师漏诊MI或ACS的比率低于1%。
- HEART评分与路径基于病史、心电图、肌钙蛋白、年龄和风险因素进行风险分层,对MACE显示高敏感性。
- 使用HEART评分时需考虑风险因素、心电图、肌钙蛋白、年龄、病史、格式塔、随访、临界评分和共享决策等细节。
- HEART路径可补充临床医生的决策。
- 未来方向可能纳入其他患者因素。
适用人群与场景
- 急诊科胸痛患者。
研究设计与关键结果
- 综述指出,急诊胸痛常见,ACS占胸痛患者少数,急诊医师漏诊MI或ACS的比率低于1%。
- HEART评分与路径基于病史、心电图、肌钙蛋白、年龄和风险因素将大量患者准确分层,对MACE显示高敏感性。
- 使用HEART评分时需考虑风险因素、心电图、肌钙蛋白、年龄、病史、格式塔、随访、临界评分和共享决策等细节。
- HEART路径可补充临床决策。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- HEART路径可补充急诊临床决策,但需综合考虑风险因素、心电图、肌钙蛋白、年龄、病史、格式塔、随访、临界评分和共享决策等关键要素。
- 作者认为未来方向可能纳入其他患者因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Chest pain accounts for a significant percentage of emergency department (ED) presentations. The HEART score and pathway have demonstrated an ability to appropriately risk stratify and discharge from the ED a significant proportion of patients.
OBJECTIVE: This review evaluates vital components of the HEART score and pathway, while discussing important considerations for current and future use.
DISCUSSION: Chest pain is a common ED presentation, and several conditions associated with chest pain result in patient morbidity and mortality. One major disease is acute coronary syndrome (ACS). Despite the fear associated with this disease, it accounts for a minority of patients with chest pain in the ED. Emergency physicians rarely miss myocardial infarction (MI) or ACS, with miss rates<1%. Many have sought a score and pathway that allow physicians to safely and reliably risk stratify patients. The HEART score and pathway have revolutionized chest pain evaluation, as they can risk stratify a significant number of patients accurately into separate categories based on history, electrocardiogram (ECG), troponin, age, and risk factors while displaying high sensitivity for MACE. Several intricacies must be considered in the use of this score including risk factors, ECG, troponin, age, history, gestalt, follow up, borderline score, and shared decision making. The HEART pathway can supplement clinician decision making.
CONCLUSIONS: Appropriate use of the HEART pathway reliably risk stratifies patients. Physicians must consider several key components when utilizing the HEART pathway, and future directions may incorporate other patient factors.
参考来源
- Long B, Oliver J, Streitz M, et al. An end-user's guide to the HEART score and pathway. Am J Emerg Med. 2017. PMID: 28363616. doi:10.1016/j.ajem.2017.03.047
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。